UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross‐sectional study

BJOG : an international journal of obstetrics and gynaecology, 2016-12, Vol.123 (13), p.2164-2170

2016

Volltextzugriff (PDF)

Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial

British journal of anaesthesia : BJA, 2017-09, Vol.119 (3), p.411-421

2017

Volltextzugriff (PDF)

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

Journal of thrombosis and haemostasis, 2009-03, Vol.7 (3), p.413-420

2009

Volltextzugriff (PDF)

Viscoelastometry guided fresh frozen plasma infusion for postpartum haemorrhage: OBS2, an observational study

British journal of anaesthesia : BJA, 2017-09, Vol.119 (3), p.422-434

2017

Volltextzugriff (PDF)

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-01, Vol.17 (1), p.2-10

2011

Volltextzugriff (PDF)

National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia

Transfusion medicine (Oxford, England), 2012-10, Vol.22 (5), p.350-355

2012

Volltextzugriff (PDF)

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

Journal of thrombosis and haemostasis, 2010-02, Vol.8 (2), p.269-275

2010

Volltextzugriff (PDF)

The diagnosis and management of factor VIII and IX inhibitors : A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)

British journal of haematology, 2000-10, Vol.111 (1), p.78-90

2000

Volltextzugriff (PDF)

Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (4), p.514-520

2016

Volltextzugriff (PDF)

Early viscoelastometric guided fibrinogen replacement combined with escalation of clinical care reduces progression in postpartum haemorrhage: a comparison of outcomes from two prospective observational studies

International journal of obstetric anesthesia, 2024-08, Vol.59, p.104209, Article 104209

2024

Volltextzugriff (PDF)

Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related differences and implications for dose tailoring

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.730-736

2010

Volltextzugriff (PDF)

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-09, Vol.10 (5), p.428-437

2004

Volltextzugriff (PDF)

Measurement of blood loss during postpartum haemorrhage

International journal of obstetric anesthesia, 2015-02, Vol.24 (1), p.8-14

2015

Volltextzugriff (PDF)

Standard haemostatic tests following major obstetric haemorrhage

International journal of obstetric anesthesia, 2011-04, Vol.20 (2), p.135-141

2011

Volltextzugriff (PDF)

Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience

Ultrasound in obstetrics & gynecology, 1999-01, Vol.13 (1), p.11-16

1999

Volltextzugriff (PDF)

The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-09, Vol.23 (5), p.728-735

2017

Volltextzugriff (PDF)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage

International journal of obstetric anesthesia, 2010-04, Vol.19 (2), p.218-223

2010

Volltextzugriff (PDF)

Increased clearance of von Willebrand factor antigen post‐DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?

Journal of thrombosis and haemostasis, 2003-08, Vol.1 (8), p.1714-1717

2003

Volltextzugriff (PDF)

Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding

Journal of thrombosis and haemostasis, 2011-02, Vol.9 (2), p.282-292

2011

Volltextzugriff (PDF)

Platelet count and transfusion requirements during moderate or severe postpartum haemorrhage

Anaesthesia, 2016-06, Vol.71 (6), p.648-656

2016

Volltextzugriff (PDF)

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-03, Vol.21 (2), p.219-226

2015

Volltextzugriff (PDF)

Results from an ultrasound‐based familial ovarian cancer screening clinic: a 10‐year observational study

Ultrasound in obstetrics & gynecology, 2003-04, Vol.21 (4), p.378-385

2003

Volltextzugriff (PDF)

A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: The development of a new logistic regression model

American journal of obstetrics and gynecology, 1999-07, Vol.181 (1), p.57-65

1999

Volltextzugriff (PDF)

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.104-112

2018

Volltextzugriff (PDF)

Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (4), p.507-513

2016

Volltextzugriff (PDF)

1 – 25 von 794

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(745)
Mit Volltextzugriff
(609)

Publikationsform

Artikel
(792)
magazinearticle
(2)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross‐sectional study

Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

Viscoelastometry guided fresh frozen plasma infusion for postpartum haemorrhage: OBS2, an observational study

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

The diagnosis and management of factor VIII and IX inhibitors : A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)

Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis

Early viscoelastometric guided fibrinogen replacement combined with escalation of clinical care reduces progression in postpartum haemorrhage: a comparison of outcomes from two prospective observational studies

Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related differences and implications for dose tailoring

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A

Measurement of blood loss during postpartum haemorrhage

Standard haemostatic tests following major obstetric haemorrhage

Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience

The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage

Increased clearance of von Willebrand factor antigen post‐DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?

Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding

Platelet count and transfusion requirements during moderate or severe postpartum haemorrhage

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison

Results from an ultrasound‐based familial ovarian cancer screening clinic: a 10‐year observational study

A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: The development of a new logistic regression model

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials

Aktive Filter

Suchergebnisse filtern